Entrepreneurs
Investment Focus
Gilde Healthcare Partners invests across the healthcare sector in early and late stage companies active in the biopharma, diagnostic and medical sectors as well as companies delivering various healthcare services.
Our venture capital activity focuses in all cases on companies developing innovative patent protected products in markets with high unmet clinical needs. In biopharma we preferably invest in companies with product pipelines. Our decision to invest at an early or late stage depends on the specific development route, associated value chain and funding strategy. Companies with proprietary technology platforms will leverage on our successful track-record in transforming technology into product platforms and engineering funding and exit strategies. In the diagnostic and medical sectors Gilde focuses primarily on clinical and commercial stage companies. Companies with diagnostic products targeting high unmet needs in established markets or products contributing significant clinical value in novel, high growth markets will recognize Gilde as a good partner to work with. In the medical sector we focus on devices and instruments with a therapeutic modality which offers superior clinical benefits to alternative (e.g. pharmacotherapy) solutions.
Our growth equity activity focuses on early, mid and late stage companies engaged in primary care, secondary care, elderly care, psychiatric care, medical aids and various service providers to the healthcare sector. Healthcare services investments are limited to Western Europe.
Investment Criteria
Gilde Healthcare Partners is interested to invest in private healthcare companies that fulfill the following criteria:
- Dedicated management with relevant industry experience and successful track record
- Product which addresses a large unmet need in a market with strong commercial potential and a manageable regulatory and adoption hurdle
- Development strategy targeting high value milestones during a funding period of three to four years
- Markets with high unmet need, high barriers to enter and realistic reimbursement criteria
- Capital efficient business model enabling to maximize value capture in the product’s value chain and minimize the capital requirements
- Funding strategy enabling realistic and attractive exit scenario’s in three to five years period
Procedure to submit your business plan
If you think that your company fits with the investment focus and criteria, we invite you to submit your business plan by completing the form submit your business plan. We will confirm receipt of your business plan by e-mail.
Evaluation
Within four weeks you will receive your initial feedback on your business plan and funding requirement. Please contact us at healthcare@gilde.nl for any questions relating to the status of your business plan is in the evaluation process.
